Biointerventional solutions for heart failure, chronic myocardial ischemia, and acute myocardial infarction


BioCardia was founded in 2002 to develop biointerventional solutions for heart failure, chronic myocardial ischemia and acute myocardial infarction and is headquartered in San Carlos, California.



March 17, 2014
BioCardia® Receives CE Mark for Morph AccessPro™ Steerable Introducer

January 10, 2014
BioCardia Receives CE Mark for New Helix™ Transendocardial Delivery Catheter

November 18, 2013
Phase II TAC-HFT Trial Shows Excellent Safety Profile, Suggests Efficacy, for Transendocardial Delivery of Two Types of Autologous Cells for Ischemic Heart Failure

October 28, 2013
Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure

July 13, 2013
BioCardia’s Helical Infusion Catheter completes case number 200 with an excellent safety profile

more news